Liver Diseases  >>  Immuncell-LC (GCC4002)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Immuncell-LC (GCC4002) / GC Biopharma
NCT01897610: Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC

Completed
2
40
RoW
Immuncell-LC, Activated T lymphocyte
GC Cell Corporation
Advanced Hepatocellular Carcinoma
07/17
07/17

Download Options